Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac
Mandate

Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac

April 11, 2022 Banking and Finance Commercial Agreements Intellectual Property M&A Corporate Crime & Compliance IT, Telecommunications and Outsourcing Real Estate and Construction Environmental Law

Eson Pac are packaging specialists providing solutions for the pharma packaging supply chain. Mayr-Melnhof Group (“MM”) has acquired 100% of the shares in Eson Pac from the majority shareholder Nalka Invest AB as well as the founding family and management minority shareholders. MM is Europe’s leading producer of cartonboard and folding cartons as well as kraft papers and uncoated fine papers.

Vinge’s team consisted of Matthias Pannier, Ulrich Ziche, Måns Håkanson and Elias Bohlin (M&A), Felix Möller and Ellen Flygt (Banking and Finance), Elin Broman and Emil Lindwall (Employment), Michael Montner (IP), Mario Saad (Commercial Agreements), Mika Jordan (IT), Tove Tullberg (Compliance), Frida Ställborn (Real Property), Johan Cederblad and Lina Österberg (Environmental law).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025